
    
      The purpose of this study is

        1. to determine whether genomic differences between drug responders and nonresponders
           predict the response of Mirtazapine and

        2. to construct the prediction model for Mirtazapine treatment in depressed patients in
           order to aid to select the genetically matching drug.
    
  